Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure: a consensus statement from the American Heart Association and American Diabetes Association
Authors:
Open Access
- 1 August 2004
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 27 (8) , 2096
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Consensus Development Conference on Antipsychotic Drugs and Obesity and DiabetesDiabetes Care, 2004
- Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure: a consensus statement from the American Heart Association and American Diabetes AssociationDiabetes Care, 2004
- Consensus Development Conference on Antipsychotic Drugs and Obesity and DiabetesDiabetes Care, 2004
- Consensus Development Conference on Antipsychotic Drugs and Obesity and DiabetesDiabetes Care, 2004
- Role of Simvastatin as an Immunomodulator in Type 2 DiabetesDiabetes Care, 2004
- Poor Control of Risk Factors for Vascular Disease Among Adults With Previously Diagnosed DiabetesJAMA, 2004
- Thiazolidinedione Use, Fluid Retention, and Congestive Heart FailureDiabetes Care, 2004
- Use of drugs, alcohol and tobacco by people with schizophrenia: case–control studyThe British Journal of Psychiatry, 2002